MTOR and neoplasm: Contrastingly, mTOR activity in T cells is inhibited by glucose competition when PD-L1 and B7-H3 expression is found in tumor cells, where it promotes aerobic glycolysis by activating the PI3K-Akt-mTOR pathway.